-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on DexCom, Raises Price Target to $120

Benzinga·10/30/2026 14:19:48
Listen to the news
Barclays analyst Christopher Pasquale maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $115 to $120.